Project
INTA, in collaboration with Teoresi MedTech, has developed the NanoAnalyzer, a device designed to revolutionize the diagnosis of traumatic brain injuries (TBI) through a simple blood test. Ideal for use in ambulances, emergency rooms, and remote areas, the device enhances access to diagnostics, particularly for pediatric and vulnerable patients, while reducing unnecessary tests and optimizing intervention times.
Client
Industries
Our added Value
Teoresi MedTech’s contribution has been pivotal in overcoming the technological challenges typical of deep tech startups. INTA, founded on advanced academic research, faces the complexities of engineering and industrializing the NanoAnalyzer, transitioning from prototyping to large-scale production. This process demands a highly specialized engineering approach to ensure reliability, precision, and scalability.
With extensive experience in complex systems integration and medical device development, Teoresi MedTech supports INTA in optimizing the NanoAnalyzer, facilitating seamless integration between the reader, cartridges, and cloud infrastructure. Teoresi MedTech’s expertise is essential to transform the product into a comprehensive, market-ready solution, addressing challenges in hardware design, data management, and compliance with medical standards. This support accelerates INTA’s industrial development process, reducing technological risks and enhancing the overall quality of the diagnostic system.
Results
Thanks to the collaboration with Teoresi MedTech, the anticipated outcomes of INTA’s NanoAnalyzer project are set to revolutionize brain trauma (TBI) diagnostics and beyond. With the ability to detect six specific biomarkers from a blood test, the device will offer a rapid, non-invasive, and portable diagnostic solution, drastically reducing the need for costly and invasive CT scans.
Key benefits include increased efficiency within healthcare systems and reduced hospital costs, accompanied by a significant improvement in patient experience, especially for vulnerable groups such as children and the elderly, through early and accurate diagnosis. These outcomes will contribute to making the healthcare system more sustainable and overall, more effective.